Johnson & Johnson

Pharmaceuticals
JNJ
$ 168 (0.39)%
Share price
$ 440 bn
Market Cap
$ 438 bn
Enterprise Value

Carbon footprint

1.7 Ton
GHG emissions per $ 1 mln investment
0.05x the weighted average for S&P 500
FY2021
How is this calculated?
+2.4%
YOY change in GHG emissions
Weaker than the +4.5% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-4.3%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

Johnson & Johnson aims to reduce Scope 1 + 2 by 60% by 2030 from a base year 2016


1.5°C
Johnson & Johnson's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Johnson & Johnson's GHG emissions (market-based) (Kt of CO2e)
Johnson & Johnson's Carbon intensity (Tons per 1 USDm)

Johnson & Johnson's carbon footprint

Johnson & Johnson reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 765 Kt (+18/+2.4% y-o-y). At the sime time, carbon intensity decreased to 8.2 t (-0.8 /-8.9% y-o-y).

Johnson & Johnson's Scope 3 emissions grew to 17,359 Kt (+864/+5.2% y-o-y). The performance has been erratic recently.

The company is committed to reducing Scope 1 + 2 by 60% by 2030 from a base year 2016, which translates into the estimated reduction of -33 Kt per annum over the period of FY2022 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Company environmental metrics

Show more...